Sandoz Stands Alone As It Completes Novartis Spinoff
Industry Giant Enters ‘New Era’ As An Independent Company After Long-Awaited Separation
Sandoz has heralded a “new era as a standalone global leader and European champion in generic and biosimilar medicines” after completing its long journey towards independence by separating from former parent company Novartis.
